Abstract:BACKGROUND:Baicalin possesses potential anti-inflammatory, anti-tumor and anti-oxidant activities. In the present study, we attempted to investigate the preventive effects of baicalin against Mycoplasma gallisepticum (MG)-induced inflammation, apoptosis and energy metabolism dysfunction in chicken lungs.METHODS:Experimental chickens were randomly divided into 1) control group, 2) MG infection group, 3) MG-infected group treated with baicalin at a dose of 450 mg/kg and 4) baicalin alone treated group (450 mg/kg). After 7 days of post-treatment, serum and lung tissues were collected for different experimental analyses. The hallmarks of inflammation, apoptosis and energy metabolism dysfunction were detected by histological and ultrastructural examination, qRT-PCR, Western blotting and terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling (TUNEL) assay.RESULTS:The level of serum inflammatory markers were increased with MG infection. Histological and ultrastructural analysis showed excessive inflammatory cells infiltrates, alveolar wall thickening, hemorrhages, mitochondrial and nuclear damage, including mitochondrial swelling and condensation of DNA in the lungs of chickens infected with MG. TUNEL assay positive-stained nuclei were significantly increased in MG infection group. In addition, the mRNA and protein expression level of energy metabolism-related genes and ATPase activities were significantly reduced. Meanwhile, MG-induced morphological and ultrastructural changes were partially disappeared with baicalin-treatment, and the level of serum inflammatory markers were significantly reduced. It has been noted that baicalin significantly attenuated MG-induced inflammation and apoptosis in the chicken lungs through the suppression of nuclear factor-kappa B and reduced extensive positive-stained apoptotic nuclei. More importantly, ATPase activities and mRNA and protein expression level of energy metabolism-related genes were significantly improved with baicalin-treatment in the lungs of chickens infected with MG.CONCLUSION:Conclusively, it has been suggested from these results that baicalin-treatment efficiently prevented MG-induced inflammation, apoptosis and energy metabolism dysfunction in the chicken lungs and provide basis for new therapeutic targets to control MG infection.

Baicalin Attenuates Mycoplasma Gallisepticum-Induced Inflammation Via Inhibition of the TLR2-NF-κB Pathway in Chicken and DF-1 Cells

Baicalin Ameliorates Mycoplasma Gallisepticum-Induced Lung Inflammation in Chicken by Inhibiting TLR6-mediated NF-κB Signalling

Baicalin alleviates Mycoplasma gallisepticum-induced oxidative stress and inflammation via modulating NLRP3 inflammasome-autophagy pathway

Baicalin Attenuatedmycoplasma Gallisepticum-Induced Immune Impairment in Chicken Bursa of Fabricius Through Modulation of Autophagy and Inhibited Inflammation and Apoptosis

Antagonistic Effects of Baicalin on Mycoplasma Gallisepticum-Induced Inflammation and Apoptosis by Restoring Energy Metabolism in the Chicken Lungs.

Revealing the mechanism: the influence of Baicalin on M1/M2 and Th1/Th2 imbalances in mycoplasma gallisepticum infection

Baicalin Ameliorates Mycoplasma Gallisepticum-Induced Inflammatory Injury in the Chicken Lung Through Regulating the Intestinal Microbiota and Phenylalanine Metabolism.

Pharmacokinetic/pharmacodynamic profiles of baicalin against Mycoplasma gallisepticum in an in vivo infection model.

Pharmacokinetic/pharmacodynamic Profiles of Baicalin Against Mycoplasma Gallisepticum in an in Vivo Infection Model

Baicalin ameliorates oxidative stress and apoptosis by restoring mitochondrial dynamics in the spleen of chickens via the opposite modulation of NF-κB and Nrf2/HO-1 signaling pathway during Mycoplasma gallisepticum infection

Baicalin relieves Mycoplasma pneumoniae infection‐induced lung injury through regulating microRNA‐221 to inhibit the TLR4/NF‐κB signaling pathway

Anti-bacterial Activity of Baicalin Against APEC Through Inhibition of Quorum Sensing and Inflammatory Responses

Baicalin Alleviated APEC-induced Acute Lung Injury in Chicken by Inhibiting NF-κB Pathway Activation.

Baicalin Ameliorates Mycoplasma Gallisepticum-Induced Inflammatory Injury Via Inhibiting STIM1-regulated Ceramide Accumulation in DF-1 Cells

Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells

Baicalin Inhibits NOD-Like Receptor Family, Pyrin Containing Domain 3 Inflammasome Activation in Murine Macrophages by Augmenting Protein Kinase A Signaling

Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways

Baicalin mitigates nephropathogenic infectious bronchitis virus infection-induced spleen injury via modulation of mitophagy and macrophage polarization in Hy-Line chick

Baicalin Protects Against APEC-Induced Colibacillosis by Regulating Gut Microbiota in Chickens

Baicalin Downregulates RLRs Signaling Pathway to Control Influenza A Virus Infection and Improve the Prognosis

The Anti-Inflammatory Effects Of Baicalin Through Suppression Of Nlrp3 Inflammasome Pathway In Lps-Challenged Piglet Mononuclear Phagocytes